Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Emmaus Life Sciences Appoints Willis C. Lee as CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Emmaus Life Sciences Appoints Willis C. Lee as CEO

Lee, who previously served as Co-President and COO, will continue to serve as Chairman of the Board.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Emmaus Life Sciences Inc. has appointed Willis C. Lee as Chief Executive Officer (CEO). 

Lee, who previously served as Co-President and Chief Operating Officer, will continue to serve as Chairman of the Board.

Lee said, “We are working hard to improve the efficiency of the company by reorganizing every level of our operations. We believe that these moves will better position us to serve our patients, clients, and shareholders, and equip us to face the challenges posed by the launch of generic L-glutamine.  As the new CEO, I will ensure that we continue to grow our market presence in the Middle East and invest in research that will expand our pipelines and increase the value of the company. In the next few months, I will work aggressively with the Board, members of the newly restructured teams, and all stakeholders to ensure that your trust in us is well justified.”

This news comes weeks after Emmaus received the “No Action Indicated” classification following an inspection by the FDA of Emmaus’ Postmarketing Adverse Drug Experience (PADE) compliance program.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters